These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10470562)

  • 1. Prophylaxis of bacterial meningitis.
    Peltola H
    Infect Dis Clin North Am; 1999 Sep; 13(3):685-710, viii. PubMed ID: 10470562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in bacterial conjugate vaccines.
    Goldblatt D
    J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapies and vaccines for bacterial meningitis.
    Foster C; Nadel S
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1051-60. PubMed ID: 12150701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugate vaccines--a breakthrough in vaccine development.
    Mäkelä PH
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemoprophylaxis in meningitis].
    Otero MC; Calvo MA; Pérez-Tamarit D; Asensi F
    Rev Esp Quimioter; 1998 Jun; 11(2):118-27. PubMed ID: 9795296
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence and aetiology of bacterial meningitis among children aged 1-59 months in South Asia: systematic review and meta-analysis.
    Ali M; Chang BA; Johnson KW; Morris SK
    Vaccine; 2018 Sep; 36(39):5846-5857. PubMed ID: 30145101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis.
    Lieberman JM; Greenberg DP; Ward JI
    Infect Dis Clin North Am; 1990 Dec; 4(4):703-29. PubMed ID: 2126022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppurative bacterial meningitis and the outlook for specific prevention].
    Demina AA; Deviatkina NP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):3-10. PubMed ID: 6429984
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial meningitis: the impact of vaccination.
    Makwana N; Riordan FA
    CNS Drugs; 2007; 21(5):355-66. PubMed ID: 17447825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implications of vaccines for prevention of bacterial meningitis.
    Riordan A
    Curr Opin Neurol; 2010 Jun; 23(3):319-24. PubMed ID: 20173637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.
    Levine OS; Knoll MD; Jones A; Walker DG; Risko N; Gilani Z
    Curr Opin Infect Dis; 2010 Jun; 23(3):236-41. PubMed ID: 20407316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years.
    Renner LA; Newman MJ; Ahadzie L; Antwi-Agyei KO; Eshetu M
    Pediatr Infect Dis J; 2007 Apr; 26(4):356-8. PubMed ID: 17414404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines against bacterial meningitis.
    Segal S; Pollard AJ
    Br Med Bull; 2004; 72():65-81. PubMed ID: 15802609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Hospital-Based Prospective Surveillance Study of Bacterial Agents Causing Meningitis and Seroprevalence of Different Serogroups of Neisseria meningitidis, Haemophilus influenzae Type b, and Streptococcus pneumoniae during 2015 to 2018 in Turkey.
    Ceyhan M; Ozsurekci Y; Tanır Basaranoglu S; Gurler N; Sali E; Keser Emiroglu M; Oz FN; Belet N; Duman M; Ulusoy E; Kurugol Z; Tezer H; Ozkaya Parlakay A; Dinleyici EC; Celik U; Celebi S; Oner AF; Solmaz MA; Karbuz A; Hatipoglu N; Devrim I; Caglar I; Bozdemir SE; Kocabas E; Gundeslioglu OO; Sutcu M; Metin Akcan O; Kuyucu N; Aktar F; Kara SS; Altay Akisoglu HO; Tuygun N; Tamburaci Uslu ZD; Karadag Oncel E; Bayhan C; Cengiz AB
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32213620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period.
    Theodoridou MN; Vasilopoulou VA; Atsali EE; Pangalis AM; Mostrou GJ; Syriopoulou VP; Hadjichristodoulou CS
    BMC Infect Dis; 2007 Aug; 7():101. PubMed ID: 17760993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.
    Parent du Châtelet I; Traore Y; Gessner BD; Antignac A; Naccro B; Njanpop-Lafourcade BM; Ouedraogo MS; Tiendrebeogo SR; Varon E; Taha MK
    Clin Infect Dis; 2005 Jan; 40(1):17-25. PubMed ID: 15614687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MenHibrix: a new combination meningococcal vaccine for infants and toddlers.
    Hale SF; Camaione L; Lomaestro BM
    Ann Pharmacother; 2014 Mar; 48(3):404-11. PubMed ID: 24353263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review.
    Davis S; Feikin D; Johnson HL
    BMC Public Health; 2013; 13 Suppl 3(Suppl 3):S21. PubMed ID: 24564188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of bacterial meningitis.
    Hart CA; Cuevas LE; Marzouk O; Thomson AP; Sills J
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():49-59. PubMed ID: 8407698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.